zum Inhalt
Header Image

01: Von der Grundlagenforschung zur ökonomischen Wertschöpfung

-
Hauptschule
Breakout / Working Group
in englischer Sprache

In der heutigen Wirtschaftswelt wird Wissen, insbesondere technologisches und wissenschaftliches Wissen, immer mehr zum wichtigsten Erfolgsfaktor einer Volkswirtschaft. Universitäten und Forschungseinrichtungen sind Produzenten und Eigentümer dieses Wissens, das zum Teil patentiert und geschützt werden soll. In einer Institution, bei der die exzellente Grundlagenforschung das oberste Ziel darstellt, sollte die finanzielle Nutzung der geistigen Eigentumsrechte sekundäres Ziel zum Hauptziel sein. Aber gleichzeitig muss die moderne Universität oder Forschungseinrichtung darauf bedacht sein, die entstehenden geistigen Eigentumsrechte als ‚Nebenprodukte‘ der Grundlagenforschung in professioneller Weise zu vermarkten, um eine weitere Einnahmequelle für Grundlagenforschung zu erschließen und zum volkswirtschaftlichen Nutzen beizutragen. Durch drei Themenkreise – (i) Verbesserung des Technologietransfers, (ii) Sind Zielkonflikte zwischen Grundlagenforschung und Technologietransfer unvermeidbar? (iii) Start-ups aus akademischen Forschungseinrichtungen – wird versucht, praxisorientiertes Erfahrungswissen der Teilnehmer zur Verfügung zu stellen.

Austrian Federal Minister for Education, Vienna
Senior Associate Provost and Chief Technology Development Officer, Office of Technology Development, Harvard University, Cambridge
Director of Technology Transfer, The Tech Transfer Unit, University of Copenhagen
Senior Patent & Licensing Manager Life Sciences, Max-Planck-Innovation GmbH, Munich
Member of the French Academy of Sciences; Director General, PALUMED, Labège
CEO & President, Femtolasers Produktions GmbH, Wien
Nobelpreisträger für Physik; Professor emeritus, Institut für Festkörperforschung, Forschungszentrum Jülich GmbH, Jülich Comment
Professor Emeritus, Department of Biological Chemistry and Former Vice President for Technology Transfer, Weizmann Institute of Science, Rehovot Chair
Head of Corporate Technology Central Eastern Europe (CEE), Siemens AG Österreich, Vienna Coordination

Dr. Sonja HAMMERSCHMID

Austrian Federal Minister for Education, Vienna

1990-1995 Wissenschaftliche Mitarbeiterin, Boehringer Ingelheim Austria GmbH
1995-1997 Wissenschaftliche Mitarbeiterin, Universität Wien (Postdoc)
1998-1999 Produktmanagerin bei Margaritella-Biotrade GmbH
1999-2005 Leiterin von Life Science Austria bei der Innovationsagentur GmbH (seit 2003 aws)
2000-2010 Investmentmanagerin der UniVenture Fonds
2002-2005 Geschäftsführerin, ARGE LISA Vienna Region
2003-2010 Leiterin des Bereichs Technologie & Innovation und Gesamtprokuristin (seit 2003) in der Austria Wirtschaftsservice GmbH (aws)
2004-2006 Geschäftsführerin der ARGE Impulsprogramm Creativwirtschaft
2008-2010 Stellvertretende Vorsitzende, Universitätsrat Veterinärmedizinische Universität Wien
2009-2010 Aufsichtsrätin Innovacell Biotechnologie AG
2010-2016 Rektorin, Veterinärmedizinische Universität Wien
seit 2010 Aufsichtsrätin Vetwidi Forschungsholding GmbH
seit 2011 Aufsichtsratsvorsitzende Kunsthalle Wien GmbH
seit 2016 Bundesministerin für Bildung und Frauen

LL.B MBA Isaac T. KOHLBERG

Senior Associate Provost and Chief Technology Development Officer, Office of Technology Development, Harvard University, Cambridge

1980 University of Strasbourg, France, Diploma for French Cultural and Historical Studies
1981 INSEAD - Institut Europeen d'Administration aux Affaires, Fountainbleau, France, M.B.A.
1982 Mennen Medical Company Ltd., Tel Aviv, Israel, Marketing Manager
1986-1989 Weizmann Institute of Science, Rehovot, Israel. Managing Director, YEDA Research & Development Co. Ltd.. Led the technology transfer program at the Weizmann Institute of Science where he negotiated multiple joint venture and royalty deals which continue to pay dividends in the multi-million dollar range
1989-1998 Vice President for Industrial Liaison, New York University Medical Center. Established and led the office of Science and Technology Administration at NYU School of Medicine, with responsibility for sponsored programs, research administration, clinical trials and technology transfer
1989-2001 New York University, NY
1994-1998 Associate Dean, Science and Technology Administration, NYU Medical Center
1999-2001 Vice Provost, Vice Dean, Industrial Liaison and Research Administration, NYU School of Medicine Established and led the technology transfer program at New York University, NYU School of Medicine and its affiliated hospitals; established and led NYU School of Medicine s Clinical Trials Development program and guided NYU's participation in and served on the Board of the Biomedical Research Alliance of New York.
2001-2005 Tel Aviv University, Israel. Chief Executive Officer, Ramot and the Economic Corporation reorganized the technology licensing operation, Ramot, at Tel Aviv University. Hired new senior staff managing a total of 28 and recruited the board, made up predominately of industrialists and venture capitalists, to whom Ramot reports. Established and led the Economic Corporation at Tel Aviv University to oversee the revenue generation centers of the University including real estate and technology transfer and the newly formed functions of publishing and E-learning.
since 2005 Harvard University, responsible for the development of translating new knowledge and innovations into practical advances beneficial to society through technology transfer based on discoveries made throughout Harvard University.

Karen LAIGAARD

Director of Technology Transfer, The Tech Transfer Unit, University of Copenhagen

1992-1993 Project Co-ordinator, University of Strathclyde, Glasgow, United Kingdom
1993-1996 Marketing Manager, The British Council Scotland, Glasgow, United Kingdom
1996-2001 International Marketing Manager, Research and Enterprise, University of Glasgow, United Kingdom
2002-2003 Head of Section, Danish Ministry of Science, Technology and Innovation, Copenhagen, Denmark
since 2003 Director of Technology Transfer, University of Copenhagen
2007 Vice-President, Association of European Science and Technology Transfer Professionals (ASTP)

Dr. Egenhard LINK

Senior Patent & Licensing Manager Life Sciences, Max-Planck-Innovation GmbH, Munich

 After his final exams in Biology at the Technical University and Ludwig Maximilians University in Munich, Germany, Egenhard Link accomplished his diploma thesis at the Max Planck Institute of Biochemistry in Martinsried. For his Ph.D. and as a Postdoc he conducted research in the Boyer Center for Molecular Medicine, Howard Hughes Medical Institute, at Yale University in New Haven, Connecticut (USA). Among other things, he elucidated the mechanisms of action of tetanus and botulinum neurotoxins.
 After five years in the United States he returned to Germany to become research associate at the Max Planck Institute for Experimental Medicine in Goettingen and to build up the small albeit profitable start-up company Synaptic Systems. In fall 2000, Egenhard Link joined Max Planck Innovation where he holds the position of Senior Patent and Licensing Manager and is responsible for Technology Transfer of Max Planck Institutes in the field of 'Life Sciences'

Ph.D. Bernard MEUNIER

Member of the French Academy of Sciences; Director General, PALUMED, Labège

1993-2006 Associate Professor at the Ecole Polytechnique, Palaiseau, France
2004-2006 President of the Centre National de la Recherche Scientifique, France (CNRS)
2000 Founder of PALUMED S.A. (4 VC's investors)
2007 President of the CiRFC fondation, University of Strasbourg

Dipl.-Ing. Andreas STINGL

CEO & President, Femtolasers Produktions GmbH, Wien

1994 Co-founder and general manager of 'Stingl OEG', Korneuburg
1997 Co-founder, CEO and President of 'Femtolasers Produktions GmbH', Vienna
2003 Co-founder and director of the board of 'Femtolasers, Inc' Boston, MA

Dr. Dr. h.c. mult. Peter Andreas GRÜNBERG

Nobelpreisträger für Physik; Professor emeritus, Institut für Festkörperforschung, Forschungszentrum Jülich GmbH, Jülich

1963-1969 Continues studies of physics at Darmstadt University of Technology, Germany, diploma 1966, doctor's degree 1969
1969-1972 Postdoctoral Fellow of National Research Council of Canada at Carleton University in Ottawa, Canada
since 1972 Research scientist at the Institute of Solid State Research at Forschungszentrum Jülich, Germany
1984 Habilitation at the University of Cologne, Germany, "Privatdozent"
1984-1985 Research stay at Argonne National Laboratory, Illinois, USA
1986 Activities in the field of antiferromagnetic coupling in Fe/Cr/Fe layers
1988 Work on the GMR effect in Jülich, Germany
1992 Appointment as adjunct professor at the University of Cologne, Germany
1998 Six-month research stay at the University of Sendai and at Tsukuba Research Centre, Japan
2004 After 32 years at Jülich, Germany, Peter Grünberg retires, but continues working
2007 Helmholtz Professorship, Forschungszentrum Jülich, Germany

Ph.D. David MIRELMAN

Professor Emeritus, Department of Biological Chemistry and Former Vice President for Technology Transfer, Weizmann Institute of Science, Rehovot

 *1938 - Buenos Aires, Argentina, Immigrated to Israel 1949
1968 Ph.D. Biochemistry of Bacterial Cell Walls, Weizmann Institute of Science, Rehovot, Israel
1968-1970 Post Doctorate, Tufts University Medical School, Boston, USA
since 1970 Faculty Member, Department of Biological Chemistry, Weizmann Institute of Science
1973 Visiting Scientist, Max-Planck-Institute, Tuebingen
1976 Associate Professor with tenure
1976-1977 University of California, Berkeley
1984 Harvard University, Cambridge, MA
1984 Full Professor, Weizmann Institute
1985 Besen-Brender Chair of Microbiology and Parasitology, Department of Biological Chemistry, Weizmann Institute of Science
1991-1992 Fogarty Scholar, National Institutes of Health, Bethesda, MD
1987-1998 Chairman of the Board of Directors, Yeda Research and Development Co. Ltd.
1989-1992 Member Board of Directors, News Datacom Corp., Jerusalem, Israel
1991-1994 Member Board of Directors, Weizmann Technological Incubator Company
1993-1998 Vice President for Technology Transfer, Weizmann Institute of Science
1995-1998 Member of Board of Directors, XTL Biotechnology, Rehovot, Israel
1996-1998 Member of Board of Directors of Portman Pharmaceuticals, Rehovot, Israel
1999-2004 Dean, Faculty of Biochemistry, Weizmann Institute of Science
1999-2001 President, Israel Society for Microbiology
2004-2012 President of Scientific Council, Conseil I.Pasteur-Weizmann I.
since 2010 Member of Executive Board of Directors, Weizmann Institute of Science

Dipl.-Ing. Dr. Gerald MURAUER

Head of Corporate Technology Central Eastern Europe (CEE), Siemens AG Österreich, Vienna

1999-2001 Studium TU Wien Wirtschaftsingenieurwesen, Dr. Dissertation: Unternehmensgründungen durch Venture Capital
2001-2002 Berater, Boston Consulting Group
2002-2005 Stv. Geschäftsführer, Wiener Wissenschafts- und Technologiefonds
2005-2007 Unternehmersgründer, Murauer & Partner
2007-2012 Managing Director, Institute of Science and Technology Austria (I.S.T. Austria)

Technologiegespräche

Timetable einblenden

21.08.2008

08:00 - 10:30Technologiebrunch gegeben von der Tiroler ZukunftsstiftungSocial
11:00 - 11:20Eröffnung durch das Europäische Forum AlpbachPlenary
11:20 - 12:00PlenumPlenary
12:00 - 12:30PlenumPlenary
13:00 - 13:45Ethik in der WissenschaftPlenary
13:45 - 14:30StammzellenPlenary
15:00 - 16:00Politik und Wissenschaft – Beratung durch WissenschaftPlenary
18:00 - 19:30BionikPlenary
19:30 - 21:30Empfang gegeben von Alcatel-Lucent Austria AGSocial

22.08.2008

07:00 - 14:00Arbeitskreis 01: Von der Grundlagenforschung zur ökonomischen WertschöpfungBreakout
07:00 - 14:00Arbeitskreis 02: Integrität in Forschung und WissenschaftBreakout
07:00 - 14:00Arbeitskreis 03: Mythen der Life Sciences und ihre KonsequenzenBreakout
07:00 - 14:00Arbeitskreis 04: Luftfahrt und UmweltBreakout
07:00 - 14:00Arbeitskreis 05: Think Tanks in ÖsterreichBreakout
07:00 - 14:00Arbeitskreis 06: Gender Mainstreaming in Forschung und Entwicklung. Realitäten wahrnehmen und visionär entscheidenBreakout
07:00 - 14:00Arbeitskreis 07: Erfolgsfaktor Mensch – Regionen im WettbewerbBreakout
07:00 - 14:00Arbeitskreis 08: Klimawandel – die Zukunft des VerkehrsBreakout
07:00 - 14:00Arbeitskreis 09: Governance der angewandten Forschung: Verantwortlichkeiten, Unabhängigkeit und RessourcenBreakout
07:00 - 14:00Arbeitskreis 10: Digital HealthcareBreakout
07:00 - 16:00Junior Alpbach – Wissenschaft und Technologie für junge MenschenBreakout
07:00 - 13:00Ö1 Kinderuni Alpbach – Wissenschaft und Technologie für KinderBreakout
08:00 - 14:00Arbeitskreis 11: Energieeffizienz – Chancen erkennen, Potenziale nutzenBreakout
08:00 - 13:00Sonderveranstaltung: Vom Stabilitätspakt für Südosteuropa zum Regionalen Kooperationsrat (RCC) – ein neuer Impuls für die europäische Perspektive des Westbalkans im Bereich Hochschulbildung und Forschung?Breakout
14:30 - 15:15Die Zukunft der Wissenschaft IPlenary
15:15 - 16:30Globaler Wettbewerb um globale TalentePlenary
18:00 - 19:30Informations- und Kommunikationsinfrastrukturen – Nervenzentren der modernen GesellschaftPlenary

23.08.2008

08:00 - 08:30Naturwissenschaftliche Bildung für eine technikorientierte GesellschaftPlenary
08:30 - 09:15Die Zukunft der Wissenschaft IIPlenary
09:15 - 09:45Die Zukunft der Umwelt und LandwirtschaftPlenary
10:00 - 10:15Junior Alpbach und Ö1 Kinderuni Alpbach 2008Plenary
10:15 - 11:15Improbable Research and the Ig Nobel prizePlenary
11:15 - 12:00Imbiss zum Abschluss der Veranstaltung, gegeben von AVL List GmbHSocial